Clinical experience with linezolid for the treatment of Nocardia infection

Clinical Infectious Diseases

Volumn 36, Issue 3, 2003, Pages 313-318

  Moylett, Edina H ^g   Pacheco, Susan E ^h   Brown Elliott, Barbara A ^a   Perry, Tracy R ^b   Buescher, E Stephen ^c   Birmingham, Mary C ^d   Schentag, Jerome J ^e   Gimbel, Joseph F ^h   Apodaca, Aaron ^f   Schwartz, Margot A ^f   Rakita, Robert M ^f   Wallace Jr , Richard J ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b Department of Pharmacy   (United States)

^c Center for Pediatric Research   (United States)

^d MILLARD FILLMORE HOSPITAL   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f VIRGINIA MASON MEDICAL CENTER   (United States)

^g TEXAS CHILDREN S HOSPITAL   (United States)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; IMIPENEM; LINEZOLID; MINOCYCLINE; SULFAMETHOXAZOLE; TOBRAMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BRAIN ABSCESS; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; CHRONIC GRANULOMATOUS DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; FEMALE; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NOCARDIA; NOCARDIA ASTEROIDES; NOCARDIA BRASILIENSIS; NOCARDIA OTITIDISCAVIARUM; NOCARDIOSIS; PRIORITY JOURNAL; RELAPSE;

ACETAMIDES; ANTI-BACTERIAL AGENTS; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NOCARDIA; NOCARDIA INFECTIONS; OXAZOLIDINONES; TREATMENT OUTCOME;

EID: 0037309919     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/345907     Document Type: Article

References (28)

1. Diekema DJ, Jones RN. Oxazolidinone antibiotics. Lancet 2001; 358:1975-82.
2. Lerner PI. Nocardiosis. Clin Infect Dis 1996; 22:891-905.
3. Wallace RJ Jr, Tsukamura M, Brown BA, et al. Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica. J Clin Microbiol 1990; 28:2726-32.
4. Torres OH, Domingo P, Pericas R, Boiron P, Montiel JA, Vazquez G. Infection caused by Nocardia farcinica: case report and review. Eur J Clin Microbiol Infect Dis 2000; 19:205-12.
5. Beaman BL, Beaman L. Nocardia species: host-parasite relationships. Clin Microbiol Rev 1994; 7:213-64.
6. Farina C, Boiron P, Goglio A, Provost F. Human nocardiosis in northern Italy from 1982 to 1992. Northern Italy Collaborative Group on Nocardiosis. Scand J Infect Dis 1995; 27:23-7.
7. Dorman SE, Guide SV, Conville PS, et al. Nocardia infection in chronic granulomatous disease. Clin Infect Dis 2002; 35:390-4.
8. Scholer HJ. Sulfonamides in experimental nocardiosis, histoplasmosis, and South American blastomycosis. Chemotherapy 1968; 13:65-80.
9. Khan Z, Al-Sayer H, Chugh TD, Chandy R, Provost F, Boiron P. Antimicrobial susceptibility profile of soil isolates of Nocardia asteroides from Kuwait. Clin Microbiol Infect 2000; 6:94-8.
10. Joshi N, Hamory BH. Drug-resistant Nocardia asteroides infection in a patient with acquired immunodeficiency syndrome. South Med J 1991; 84:1155-6.
11. Gordin FM, Simon GL, Wofsy CB, Mills J. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1984; 100:495-9.
12. Brown-Elliott BA, Ward SC, Crist CJ, Mann LB, Wilson RW, Wallace RJ Jr. In vitro activities of linezolid against multiple Nocardia species. Antimicrob Agents Chemother 2001; 45:1295-7.
13. Vera-Cabrera L, Gomez-Flores A, Escalante-Fuentes WG, Welsh O. In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis. Antimicrob Agents Chemother 2001; 45:3629-30.
14. Steingrube VA, Wilson RW, Brown BA, et al. Rapid identification of clinically significant species and taxa of aerobic actinomycetes, including Actinomadura, Gordona, Nocardia, Rhodococcus, Streptomyces, and Tsukamurella isolates, by DNA amplification and restriction endonuclease analysis. J Clin Microbiol 1997; 35:817-22.
15. Woods GL, Brown-Elliott BA, Desmond EP, et al. Susceptibility testing of mycobacteria, Nocardia, and other aerobic actinomycetes: tentative standards, 2nd ed. M24-T2. Wayne, PA: National Committee for Clinical Laboratory Standards, 2001.
16. Apodaca A, Rakita RM. Linezolid induced lactic acidosis [letter]. N Engl J Med (in press).
17. Loeffler JM, Bodmer T, Zimmerli W, Leib SL. Nocardial brain abscess: observation of treatment strategies and outcome in Switzerland from 1992 to 1999. Infection 2001; 29:337-41.
18. Wallace RJ Jr, Septimus EJ, Williams TW Jr, et al. Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis 1982; 4:315-25.
19. Woods WG, Daigle AE, Hutchinson RJ, Robison LL. Myelosuppression associated with co-trimoxazole as a prophylactic antibiotic in the maintenance phase of childhood acute lymphocytic leukemia. J Pediatr 1984; 105:639-44.
20. Crespo M, Quereda C, Pascual J, Rivera M, Clemente L, Cano T. Patterns of sulfadiazine acute nephrotoxicity. Clin Nephrol 2000; 54:68-72.
21. Boiron P, Provost F, Chevrier G, Dupont B. Review of nocardial infections in France 1987 to 1990. Eur J Clin Microbiol Infect Dis 1992;11:709-14.
22. Overkamp D, Waldmann B, Lins T, Lingenfelser T, Petersen D, Eggstein M. Successful treatment of brain abscess caused by Nocardia in an immunocompromised patient after failure of co-trimoxazole. Infection 1992; 20:365-6.
23. Lo W, Rolston KV. Use of imipenem in the treatment of pulmonary nocardiosis. Chest 1993; 103:951-2.
24. Garlando F, Bodmer T, Lee C, Zimmerli W, Pirovino M. Successful treatment of disseminated nocardiosis complicated by cerebral abscess with ceftriaxone and amikacin: case report. Clin Infect Dis 1992; 15:1039-40.
25. Yew WW, Wong PC, Kwan SY, Chan CY, Li MS. Two cases of Nocardia asteroides sternotomy infection treated with ofloxacin and a review of other active antimicrobial agents. J Infect 1991; 23:297-302.
26. Stamm AM, McFall DW, Dismukes WE. Failure of sulfonamides and trimethoprim in the treatment of nocardiosis. Arch Intern Med 1983; 143:383-5.
27. Villani P, Regazzi MB, Marubbi F, et al. Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections. Antimicrob Agents Chemother 2002; 46:936-7.
28. Shaikh ZH, Peloquin CA, Ericsson CD. Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review. Scand J Infect Dis 2001; 33:375-9.